Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

A retrospective single-center pilot study of the genetic background of the transplanted kidney

A. Novotna, K. Horackova, J. Soukupova, P. Zemankova, P. Nehasil, P. Just, L. Voska, P. Kleiblova, S. Rajnochova Bloudickova

. 2025 ; 20 (1) : e0316192. [pub] 20250108

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25010309

INTRODUCTION: Renal cell carcinoma (RCC) is one of the most prevalent cancers in kidney transplant recipients (KTR). The hereditary background of RCC in native kidneys has been determined, implicating its clinical importance. MATERIALS AND METHODS: This retrospective single-center pilot study aimed to identify a potential genetic predisposition to RCC of the transplanted kidney and outcome in KTR who underwent single kidney transplantation between January 2000 and December 2020 and manifested RCC of the transplanted kidney. Next-generation sequencing (NGS) based germline genetic analysis from peripheral blood-derived genomic DNA (gDNA) was performed in both the recipient and donor using a gene panel targeting 226 cancer predisposition genes. RESULTS: The calculated incidence of RCC of the transplanted kidney among 4146 KTR was 0.43%. In fifteen KTR and donors, NGS was performed. The mean KTR age at transplantation and the diagnosis of RCC was 50.3 years (median 54; 5-67 years) and 66 years (median 66; 24-79 years), respectively. The mean donor age at transplantation and graft age at RCC diagnosis was 39.7 years (median 42; 7-68 years) and 50.2 years (median 46; 20-83 years), respectively. The mean follow-up after RCC diagnosis was 47 months (median 39.1; 0-112 months). Papillary RCC was the most prevalent (n = 8), followed by clear cell RCC (n = 6) and unspecified RCC (n = 1). Thirteen RCCs were low-stage (pT1a/b) diseases, one was pT3, and one was of unknown stage. Most RCC was higher graded. No germline pathogenic cancer-predisposition variant was found in either KTR or donors except for several variants of uncertain significance. CONCLUSION: RCC of the transplanted kidney is very rare. Germline cancer-predisposition testing has identified several variants of uncertain significance, but no germline genetic predisposition to graft RCC in KTR. Further research is needed to assess the clinical relevance of genetic testing for cancer risk in KTR.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25010309
003      
CZ-PrNML
005      
20250429135247.0
007      
ta
008      
250415s2025 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0316192 $2 doi
035    __
$a (PubMed)39777909
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Novotna, Anna $u Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
245    12
$a A retrospective single-center pilot study of the genetic background of the transplanted kidney / $c A. Novotna, K. Horackova, J. Soukupova, P. Zemankova, P. Nehasil, P. Just, L. Voska, P. Kleiblova, S. Rajnochova Bloudickova
520    9_
$a INTRODUCTION: Renal cell carcinoma (RCC) is one of the most prevalent cancers in kidney transplant recipients (KTR). The hereditary background of RCC in native kidneys has been determined, implicating its clinical importance. MATERIALS AND METHODS: This retrospective single-center pilot study aimed to identify a potential genetic predisposition to RCC of the transplanted kidney and outcome in KTR who underwent single kidney transplantation between January 2000 and December 2020 and manifested RCC of the transplanted kidney. Next-generation sequencing (NGS) based germline genetic analysis from peripheral blood-derived genomic DNA (gDNA) was performed in both the recipient and donor using a gene panel targeting 226 cancer predisposition genes. RESULTS: The calculated incidence of RCC of the transplanted kidney among 4146 KTR was 0.43%. In fifteen KTR and donors, NGS was performed. The mean KTR age at transplantation and the diagnosis of RCC was 50.3 years (median 54; 5-67 years) and 66 years (median 66; 24-79 years), respectively. The mean donor age at transplantation and graft age at RCC diagnosis was 39.7 years (median 42; 7-68 years) and 50.2 years (median 46; 20-83 years), respectively. The mean follow-up after RCC diagnosis was 47 months (median 39.1; 0-112 months). Papillary RCC was the most prevalent (n = 8), followed by clear cell RCC (n = 6) and unspecified RCC (n = 1). Thirteen RCCs were low-stage (pT1a/b) diseases, one was pT3, and one was of unknown stage. Most RCC was higher graded. No germline pathogenic cancer-predisposition variant was found in either KTR or donors except for several variants of uncertain significance. CONCLUSION: RCC of the transplanted kidney is very rare. Germline cancer-predisposition testing has identified several variants of uncertain significance, but no germline genetic predisposition to graft RCC in KTR. Further research is needed to assess the clinical relevance of genetic testing for cancer risk in KTR.
650    _2
$a lidé $7 D006801
650    12
$a transplantace ledvin $x škodlivé účinky $7 D016030
650    _2
$a lidé středního věku $7 D008875
650    _2
$a pilotní projekty $7 D010865
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a dospělí $7 D000328
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a mužské pohlaví $7 D008297
650    12
$a karcinom z renálních buněk $x genetika $7 D002292
650    _2
$a senioři $7 D000368
650    12
$a nádory ledvin $x genetika $7 D007680
650    _2
$a dítě $7 D002648
650    _2
$a mladiství $7 D000293
650    _2
$a genetická predispozice k nemoci $7 D020022
650    _2
$a mladý dospělý $7 D055815
650    _2
$a vysoce účinné nukleotidové sekvenování $7 D059014
650    _2
$a předškolní dítě $7 D002675
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a dárci tkání $7 D014019
655    _2
$a časopisecké články $7 D016428
700    1_
$a Horackova, Klara $u First Faculty of Medicine, Institute of Medical Biochemistry and Laboratory Diagnostics, Charles University and General University Hospital in Prague, Prague, Czech Republic $1 https://orcid.org/0000000273904751
700    1_
$a Soukupova, Jana $u First Faculty of Medicine, Institute of Medical Biochemistry and Laboratory Diagnostics, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Zemankova, Petra $u First Faculty of Medicine, Institute of Medical Biochemistry and Laboratory Diagnostics, Charles University and General University Hospital in Prague, Prague, Czech Republic $u First Faculty of Medicine, Institute of Pathological Physiology, Charles University, Prague, Czech Republic
700    1_
$a Nehasil, Petr $u First Faculty of Medicine, Institute of Medical Biochemistry and Laboratory Diagnostics, Charles University and General University Hospital in Prague, Prague, Czech Republic $u First Faculty of Medicine, Institute of Pathological Physiology, Charles University, Prague, Czech Republic $u Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Just, Pavel $u First Faculty of Medicine, Institute of Medical Biochemistry and Laboratory Diagnostics, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Voska, Ludek $u Department of Clinical and Transplant Pathology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Kleiblova, Petra $u First Faculty of Medicine, Institute of Medical Biochemistry and Laboratory Diagnostics, Charles University and General University Hospital in Prague, Prague, Czech Republic $u First Faculty of Medicine, Institute of Biology and Medical Genetics, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Rajnochova Bloudickova, Silvie $u Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $1 https://orcid.org/000000030270571X
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 20, č. 1 (2025), s. e0316192
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39777909 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429135242 $b ABA008
999    __
$a ok $b bmc $g 2311585 $s 1247390
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 20 $c 1 $d e0316192 $e 20250108 $i 1932-6203 $m PloS one $n PLoS One $x MED00180950
LZP    __
$a Pubmed-20250415

Najít záznam

Citační ukazatele

Možnosti archivace